Device Trial Radar · NCT05162989
iCare HOME2 Clinical Trial
Last checked: Nov 19, 2026Latest source record: Dec 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
47
Actual
Start
Nov 26, 2021
Primary completion
Dec 15, 2021
Study completion Dec 15, 2021
Sponsor
- Lead sponsor
- Icare Finland OyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 20, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this clinical study is to provide information about the variability of the intraocular pressure (IOP) self-measurements with the iCare HOME2 tonometer in comparison to the variability of the IOP measurements with the reference tonometer (iCare IC200), over a wide range of IOP values.
Conditions
- Intraocular Pressure
- Glaucoma
Interventions
iCare HOME2 vs iCare IC200Device
Measurement of IOP with iCare HOME2 compared with iCare IC200.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Repeatability of IOP measurementsTime frame: Through study completion, an average of 1-2 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
East West Eye Institute
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.